Caroline Robert - Concepedia

Author

Caroline Robert

Also Known As

C ROBERT, C Robert, C Robert-Knebelmann, C. ROBERT, C. Robert, CAROLINE ROBERT, Caroline Robert, Caroline Robert-Knebelmann, Cauquil, C., Charlotte Robert

1.5K

Publications

156.1K

Citations

154

H-Index

241

Concepts

All Affiliations

Institut Gustave Roussy Inserm Université Paris-Saclay Melanoma Institute Australia The University of Sydney

About

Caroline Robert is an author at Institut Gustave Roussy specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	88	244	46.6K
2	Health Sciences	29	51	7K
3	Engineering	3	3	1K
4	Natural Sciences	3	3	366
5	Nursing	1	1	20

Caroline Robert

451

Publications

139.3K

Citations

139

H-Index

Page 1

	Year	Citations
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma F. Stephen Hodi, Steven O’Day, David F. McDermott, New England Journal of Medicine	2010	14.9K
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation Paul B. Chapman, Axel Hauschild, Caroline Robert, New England Journal of Medicine	2011	7.6K
PD-1 blockade induces responses by inhibiting adaptive immune resistance Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley, Nature MedicineImmunologyTumor ImmunityAutoimmunityImmunomodulation	2014	6.5K
Pembrolizumab versus Ipilimumab in Advanced Melanoma Caroline Robert, Jacob Schachter, Georgina V. Long, New England Journal of Medicine	2015	5.7K
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation Caroline Robert, Georgina V. Long, Benjamin Brady, New England Journal of Medicine	2014	5.3K
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma Caroline Robert, L. Thomas, Igor Bondarenko, New England Journal of Medicine	2011	4.4K
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma Omid Hamid, Caroline Robert, Adil Daud, New England Journal of Medicine	2013	3.4K
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota Marie Vétizou, Jonathan M. Pitt, Romain Daillère, Science	2015	3.3K
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma Michael A. Postow, Jason Chesney, Anna C. Pavlick, New England Journal of Medicine	2015	2.7K
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib Caroline Robert, Bogusława Karaszewska, Jacob Schachter, New England Journal of Medicine	2014	2.6K

Page 1